Finance Watch: More Good To Come? CG Oncology Grosses $380m In Year’s First IPO
Upsized Offering With Stock Nearly Doubling In First Day
Public Company Edition: CG Oncology grossed $380m in the first biopharma IPO in the US in 2024. Follow-on offerings have been robust recently, with Edgewise and Immatics grossing $240m and $175m, respectively.
